ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

Welcome to the Brand page for “ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML”, which is offered here for The mark consists of the literal elements ethiqa xr, stylized, with the left-hand portion of the x enhanced by three stippled outlines of varying shading. at the below are the literal elements (buprenorphine extended release injectable suspension) 1.3 mg/ml.;pharmaceutical preparations, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals;ethiqa xr (buprenorphine extended-release injectable suspension) one point three mg/ml;color is not claimed as a feature of the mark.;xr and (buprenorphine extended-release injectable suspension) 1.3 mg/ml;.

Its status is currently believed to be active. Its class is unavailable. “ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML” is believed to be currently owned by “FIDELIS ANIMAL HEALTH, INC.”